These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38960425)

  • 21. Laboratory diagnosis of acute measles infections in hospitalized children in Zambia.
    Oshitani H; Suzuki H; Mpabalwani M; Mizuta K; Kasolo FC; Luo NP; Numazaki Y
    Trop Med Int Health; 1997 Jul; 2(7):612-6. PubMed ID: 9270728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis.
    Latner DR; McGrew M; Williams N; Lowe L; Werman R; Warnock E; Gallagher K; Doyle P; Smole S; Lett S; Cocoros N; DeMaria A; Konomi R; Brown CJ; Rota PA; Bellini WJ; Hickman CJ
    Clin Vaccine Immunol; 2011 Jan; 18(1):35-42. PubMed ID: 21047998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.
    Pebody RG; Gay NJ; Hesketh LM; Vyse A; Morgan-Capner P; Brown DW; Litton P; Miller E
    Vaccine; 2002 Jan; 20(7-8):1134-40. PubMed ID: 11803074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of RNA amplification by multiplex RT-PCR and IgM detection by indirect and capture ELISAs for the diagnosis of measles and rubella.
    Sanz JC; Mosquera M; Ramos B; Ramírez R; de Ory F; Echevarria JE
    APMIS; 2010 Mar; 118(3):203-9. PubMed ID: 20132186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil.
    Oliveira MI; Curti SP; Figueiredo CA; Afonso AM; Theobaldo M; Azevedo RS; Durigon EL
    Rev Saude Publica; 2002 Apr; 36(2):155-9. PubMed ID: 12045795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
    Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
    Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
    Kontio M; Jokinen S; Paunio M; Peltola H; Davidkin I
    J Infect Dis; 2012 Nov; 206(10):1542-8. PubMed ID: 22966129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset.
    Helfand RF; Heath JL; Anderson LJ; Maes EF; Guris D; Bellini WJ
    J Infect Dis; 1997 Jan; 175(1):195-9. PubMed ID: 8985220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring of implementation of international programs of poliomyelitis eradication and measles and rubella elimination in the Republic of Belarus].
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):21-30. PubMed ID: 22442967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mumps, measles and rubella vaccination in children with PFAPA syndrome.
    Kraszewska-Głomba B; Matkowska-Kocjan A; Miśkiewicz K; Szymańska-Toczek Z; Wójcik M; Banyś D; Szenborn L
    Vaccine; 2016 Nov; 34(48):5903-5906. PubMed ID: 27997341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological findings during a measles outbreak occurring in a population with high vaccine coverage.
    Oliveira SA; Siqueira MM; Costa AJ; Almeida MT; Nascimento JP
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):421-5. PubMed ID: 8729752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G; Peña B; Marimón JM; Pérez-Trallero E
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.